Bloomberg Daybreak Asia: Trump Tariff Plans, TikTok Order Signed

US equities, with the S&P 500 experiencing its longest slide in a month, fell due to valuation concerns despite strong GDP data, while short-dated yields climbed. Concurrently, President Trump advanced plans for American investors to acquire TikTok's US operations for $14 billion, ensuring security and compliance with a 2024 law. Additionally, Trump announced new tariffs, including a 100% duty on branded pharmaceuticals effective October 1 unless companies establish US manufacturing, indicating significant policy shifts for the tech and healthcare industries.

Analysis

US equity markets are exhibiting signs of fatigue, with the S&P 500 marking its longest losing streak in a month despite data showing US GDP growing at the fastest pace in nearly two years. This divergence suggests that elevated valuation concerns are currently outweighing positive macroeconomic fundamentals. The concurrent rise in short-dated yields, even as Federal Reserve expectations remain stable, indicates the bond market may be pricing in higher policy uncertainty or reacting to the strong growth figures. This market backdrop is further complicated by significant, policy-driven events. The administration's advancement of a $14 billion deal for the US acquisition of TikTok's operations signals a resolution to a specific geopolitical issue but also sets a precedent for forced divestitures. Simultaneously, the announcement of a 100% tariff on branded pharmaceuticals, effective October 1 unless companies commit to US manufacturing, introduces a substantial and immediate risk for the healthcare sector, potentially forcing a rapid realignment of global supply chains and capital expenditure plans.

Key Decisions for Investors

• Given the market's negative reaction to strong GDP, investors should scrutinize portfolios for over-exposure to high-valuation growth stocks, which are particularly vulnerable to rising short-term yields and shifts in risk sentiment.
• A mandatory review of pharmaceutical holdings is necessary to assess vulnerability to the impending 100% tariff, differentiating between companies with established US manufacturing and those with high import dependency.
• Monitor policy-driven risk as a primary factor, as executive actions in both M&A and trade are creating significant, sector-specific event risk for technology and healthcare.
• Consider the rising short-dated yields as a signal to potentially shorten duration in fixed-income portfolios and to brace for continued pressure on equity multiples if the trend persists.